Caremark Issues Statement on Questcor's (QCOR) Acthar Gel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Questcor (QCOR) Updates on Study of Acthar for MS Patients When Regular Treatment Doesn't
March 11, 2013 11:42 AM EDTQuestcor (Nasdaq: QCOR) shares are on the rise following more positive data tied to its ACTH treatment, Acthar.
According to Bloomberg, the American Academy Neurology released data from a new study outlining the benefits of Acthar on multiple sclerosis (MS) which isn't being well controlled via regular treatment. The release, posted on Science Daily is reprinted below:
A new study suggests that treatment with adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple sclerosis (MS) is not well-controlled through their regular treatment. The study was released... More
Questcor (QCOR) Updates on Study of Acthar for MS Patients When Regular Treatment Doesn't
March 11, 2013 11:42 AM EDTQuestcor (Nasdaq: QCOR) shares are on the rise following more positive data tied to its ACTH treatment, Acthar.
According to Bloomberg, the American Academy Neurology released data from a new study outlining the benefits of Acthar on multiple sclerosis (MS) which isn't being well controlled via regular treatment. The release, posted on Science Daily is reprinted below:
A new study suggests that treatment with adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple sclerosis (MS) is not well-controlled through their regular treatment. The study was released... More
